isabelobrien, Author at European Medical Journal - Page 16 of 65

New investor network targets women’s health gap

WHAM’s Innovator’s Circle unites top funds to address the women’s health investment gap.

A spray of red and blue stars

Trump’s drug pricing order hits pharma stocks

Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms.

Airplane on blue background

New air cargo project links medicine and agriculture

The initiative is set to revolutionise healthcare delivery and agricultural exports in low- and middle-income countries.

Diu Nguyen

Hema Now: Episode 16: A Journey Through Leukaemia Research

Diu Nguyen, Lecturer and Group Leader at the Centre for Haemato-Oncology, Barts Cancer Institute, joins the podcast to discuss breakthroughs in acute myeloid leukaemia (AML) research

Purple briefcase on grey background

BMS names Cari Gallman as new General Counsel

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.

The word spotlight on a blue background

Spotlight: April 2025

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Lilly partners with Alchemab for ALS candidate

Eli Lilly joins forces with Alchemab in a deal worth $415m, expanding its neuroscience pipeline with a novel candidate.

US unveils new universal vaccine platform

Generation Gold Standard is a universal vaccine platform targeting influenza, coronaviruses and future pandemics.

Handshake on green background

Novartis acquires Regulus Therapeutics and potential first-in-class therapeutic

Novartis announces acquisition of Regulus Therapeutics, adding a potential first-in-class miR-17 inhibitor to its renal pipeline.

Hidden heroes of healthcare: Reaching NPs and PAs

Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.